Lucintel's latest market report analyzed that subcutaneous drug delivery device provides attractive opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy channels. The subcutaneous drug delivery device market is expected to reach $49.9 billion by 2030 with a CAGR of 10.5%. In this market, pen injector is the largest segment by product, whereas retail pharmacy is largest...